New drug SON-1010 tested in advanced cancer patients
NCT ID NCT05352750
First seen Feb 03, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This early-phase study tests a new drug called SON-1010 in 42 adults with advanced solid tumors that have spread. The main goals are to check safety and find the highest safe dose. Researchers will also measure drug levels in blood and urine and look at immune system changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
Conditions
Explore the condition pages connected to this study.